Journal of Applied Biotechnology Reports

Journal of Applied Biotechnology Reports

Journal of Applied Biotechnology Reports (JABR) is a quarterly, international, peer-reviewed, and open-access journal dedicated to the various disciplines of Applied Biotechnology. The journal publishes original/research articles, review articles, mini-reviews, short communications, letters to the editors, commentaries, and editorials.

Journal of Applied Biotechnology Reports (JABR) is a new platform for presenting and publishing biotechnology research. The journal publishes strictly peer-reviewed papers that cover novel aspects and methods across all areas of biotechnology. It provides a medium for the rapid publication of full-length articles, short communications, and technical reports on novel and innovative aspects of biotechnology. The Journal of Applied Biotechnology Reports also welcomes Review Articles. The journal has 4 issues per year that are published concurrently in English, and all officially accepted manuscripts will be immediately published online. The journal also encourages the submission of useful reports of negative results.

Submitted manuscripts should present new results of original research or describe new theoretical or methodological approaches in biotechnology. Original articles of no more than five typed pages, including figures, tables, and references, are published as short communications. This journal accepts articles in all fields of biotechnology, especially DNA/Protein Engineering, all Cell Analysis fields (Genomics, Proteomics, Metabolomics, Systems biology, etc.), Bioinformatics (Docking and Modeling), Imaging, Analytical Biotechnology (Sensors/Detectors for Analytes/Macromolecules), Plant/Agricultural, Food, Microbial or Environmental Biotechnology, Health and Therapeutical Biotechnology (Including Antisense/siRNAs and PNAs, Enzymes, Peptides ...), Regenerative Medicine (Stem cells, Tissue engineering, and Biomaterials), Translational Immunology (Antibody engineering, Xenotransplantation, T-cell therapies), Medical Biotechnology, Biosafety or Biosecurity.

Article Processing Charges
 

The JABR publishes all its manuscripts in full open access, meaning unlimited use and reuse of articles, in addition to giving credit to the authors. 

Iranian authors must pay Article Processing Charges (APC), which cover the costs of peer review administration and management, designing, professional production of articles in PDF and other formats, and dissemination of published papers in various venues, in addition to other publishing functions. 

There are no charges for rejected articles, no submission charges, and no charges based on the length of an article, figures, or supplementary data. Please note that these fees apply only to accepted articles. 

The APC for Iranian authors is 10,000,000 Rials, and authors from other countries do not need to pay the APC.

 

Declaration of Generative AI and AI-assisted Technologies

During the preparation of this work, the author(s) used [NAME TOOL/ SERVICE] to [REASON]. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.

 

Frequency: 4 Issues per Year

Current Issue: Volume 13, Issue 1, Winter 2026, Pages 1889-1992 

Cellular Receptors and their Associated Factors for SARS-CoV-2 Entry Designing Susceptible Cells: A review

Pages 1889-1898

10.30491/jabr.2025.518549.1868

Seyed Kiarash Aghayan, Mohammad Reza Heydari, Amir Yousefkhany, Yousef Tarvedizadeh, Majid Mirzaei Nodooshan, Ali Salimi Jeda, Hadi Esmaeili Gouvarchin Ghaleh, Mostafa Eslami Mahmoudabadi